No price range yet · latest SEC filing Oct 7, 2026.
Pinch-zoom for details.
Medical device company making total disc replacement implants for the neck and lower back.
Fiscal year
1st half
Fiscal year
1st half
Share of voting power held by the founders or controlling holders after the offering, as stated in the filing.
| $ | FY2024 | FY2025 | YoY | H1 2025 | H1 2026 | Change |
|---|---|---|---|---|---|---|
| Revenue | 95.1M | 132M | +39.0% | 60.1M | 85.2M | +41.9% |
| Net result | (12.1M) | (4.32M) | +64.4% | (503K) | 10.2M | n/m |
| $ | FY2024 | FY2025 | YoY |
|---|---|---|---|
| Revenue | 95.1M | 132M | +39.0% |
| Net result | (12.1M) | (4.32M) | +64.4% |
| $ | H1 2025 | H1 2026 | Change |
|---|---|---|---|
| Revenue | 60.1M | 85.2M | +41.9% |
| Net result | (503K) | 10.2M | n/m |
Values as filed, shortened (K = thousand, M = million, B = billion); losses in parentheses. Change columns compare each period with the same period a year earlier; a bigger loss shows as a negative change. Green is better for the company, red worse; n/m where the sign flips.
The filing's own risk-factor headings, shortened.
The filing doesn't set out its strategy in a list we could read.
Source: Centinel Spine Holdco, Inc.'s Form S-1, filed with the SEC on Oct 7, 2026 (preliminary prospectus). Figures are as filed; changes are worked out from them. Not investment advice.
Pinch-zoom for details.
10KDecoder (10-K Decoder): decode SEC 10-K filings and IPO prospectuses into dashboards and infographics.
Infographic
Double-tap: full screen or back